Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Preferred Dividend Payments (2019 - 2020)

Harmony Biosciences Holdings (HRMY) has disclosed Preferred Dividend Payments for 2 consecutive years, with $6.0 million as the latest value for Q3 2020.

  • Quarterly Preferred Dividend Payments fell 33.39% to $6.0 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $26.9 million through Dec 2020, changed N/A year-over-year, with the annual reading at $26.9 million for FY2020, 23.64% down from the prior year.
  • Preferred Dividend Payments hit $6.0 million in Q3 2020 for Harmony Biosciences Holdings, down from $10.4 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $10.4 million in Q2 2020 to a low of $6.0 million in Q3 2020.